| Systemic lupus erythematosus |
1.71 |
2.42e-1 |
45/135 (33.33%) |
C7;C1QB;HLA-DQA1;...
|
| Protein digestion and absorption |
1.62 |
3.62e-1 |
78/103 (75.73%) |
COL14A1;COL6A1;COL6A2;...
|
| Amoebiasis |
1.60 |
3.31e-1 |
99/102 (97.06%) |
LAMA2;SERPINB4;SERPINB3;...
|
| Protein export |
1.58 |
3.00e-1 |
17/23 (73.91%) |
OXA1L;SRP54;SEC11A;...
|
| Cytokine-cytokine receptor interaction |
1.56 |
2.82e-1 |
246/295 (83.39%) |
CCL20;BMP2;LTB;...
|
| Complement and coagulation cascades |
1.54 |
2.83e-1 |
76/85 (89.41%) |
C7;C1QB;CFD;...
|
| Tyrosine metabolism |
1.52 |
2.96e-1 |
30/36 (83.33%) |
ADH1C;TYRP1;ADH5;...
|
| Staphylococcus aureus infection |
1.50 |
3.08e-1 |
72/95 (75.79%) |
DEFB1;C1QB;HLA-DQA1;...
|
| Maturity onset diabetes of the young |
1.50 |
2.74e-1 |
21/26 (80.77%) |
HHEX;GCK;IAPP;...
|
| Prion disease |
1.48 |
2.89e-1 |
209/273 (76.56%) |
C7;C1QB;NDUFS2;...
|
| Drug metabolism |
1.48 |
2.70e-1 |
78/151 (51.66%) |
ADH1C;ADH5;GSTT1;...
|
| TGF-beta signaling pathway |
1.47 |
2.53e-1 |
81/94 (86.17%) |
BMP2;ID3;ID1;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.45 |
2.70e-1 |
84/100 (84%) |
CCL20;TNFRSF10B;CCL13;...
|
| Malaria |
1.43 |
2.98e-1 |
44/50 (88%) |
SDC1;SDC2;THBS2;...
|
| Spliceosome |
1.42 |
2.94e-1 |
101/150 (67.33%) |
SRSF6;SNRNP40;SNRPA1;...
|
| Retinol metabolism |
1.42 |
2.82e-1 |
41/68 (60.29%) |
ADH1C;ADH5;DHRS9;...
|
| Rheumatoid arthritis |
1.41 |
3.05e-1 |
78/93 (83.87%) |
CCL20;LTB;HLA-DQA1;...
|
| Coronavirus disease |
1.40 |
2.95e-1 |
215/232 (92.67%) |
C7;NFKBIB;RPL10;...
|
| DNA replication |
1.39 |
3.06e-1 |
34/36 (94.44%) |
MCM5;MCM7;POLE2;...
|
| Pertussis |
1.34 |
4.20e-1 |
64/76 (84.21%) |
IRAK1;C1QB;C1QA;...
|
| Toxoplasmosis |
1.32 |
4.44e-1 |
103/112 (91.96%) |
NFKBIB;LAMA2;IRAK1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.32 |
4.33e-1 |
49/77 (63.64%) |
ADH1C;ADH5;GSTT1;...
|
| Ribosome |
1.30 |
4.62e-1 |
113/158 (71.52%) |
RPL10;RPS27L;RPS17;...
|
| Thyroid hormone synthesis |
1.29 |
4.82e-1 |
66/75 (88%) |
GPX1;SERPINA7;DUOX2;...
|
| RNA transport |
1.28 |
4.81e-1 |
128/186 (68.82%) |
EIF1AY;NUP85;NUP62;...
|
| Th1 and Th2 cell differentiation |
1.27 |
4.83e-1 |
80/92 (86.96%) |
NFKBIB;NFATC3;HLA-DQA1;...
|
| Arginine biosynthesis |
1.26 |
5.02e-1 |
17/22 (77.27%) |
CPS1;GLS2;GLS;...
|
| IL-17 signaling pathway |
1.25 |
5.24e-1 |
84/94 (89.36%) |
CCL20;MUC5B;S100A7;...
|
| NF-kappa B signaling pathway |
1.24 |
5.23e-1 |
90/104 (86.54%) |
LTB;IRAK1;CCL13;...
|
| Intestinal immune network for IgA production |
1.23 |
5.24e-1 |
38/48 (79.17%) |
HLA-DQA1;CXCL12;CD40;...
|
| Other glycan degradation |
-1.36 |
3.39e-1 |
13/18 (72.22%) |
MAN2C1;NEU1;FUCA1
|
| Tryptophan metabolism |
-1.36 |
3.47e-1 |
35/42 (83.33%) |
KYAT1;IDO1;ALDH7A1;...
|
| Insulin signaling pathway |
-1.36 |
3.46e-1 |
121/137 (88.32%) |
INPP5A;PRKCZ;PYGB;...
|
| Choline metabolism in cancer |
-1.37 |
3.46e-1 |
84/98 (85.71%) |
CHPT1;MAPK3;PRKCB;...
|
| Gastric acid secretion |
-1.39 |
3.35e-1 |
63/76 (82.89%) |
CFTR;ADCY3;KCNK10;...
|
| Oxytocin signaling pathway |
-1.39 |
3.46e-1 |
128/154 (83.12%) |
HRAS;PPP1R12A;RHOA;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
-1.40 |
3.31e-1 |
70/77 (90.91%) |
ITGA8;ATP2A1;CACNG2;...
|
| Thyroid cancer |
-1.41 |
3.14e-1 |
36/37 (97.3%) |
GADD45A;HRAS;GADD45G;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
-1.41 |
3.24e-1 |
49/53 (92.45%) |
ATP2B1;RAB11A;ATP1A3;...
|
| Regulation of lipolysis in adipocytes |
-1.42 |
3.32e-1 |
52/55 (94.55%) |
PRKACA;AKT1;ADORA1;...
|
| Glutamatergic synapse |
-1.43 |
3.14e-1 |
97/114 (85.09%) |
SLC1A6;GNG7;SLC1A2;...
|
| Bacterial invasion of epithelial cells |
-1.44 |
3.17e-1 |
59/77 (76.62%) |
RHOA;HCLS1;ARPC5;...
|
| FoxO signaling pathway |
-1.44 |
3.24e-1 |
118/131 (90.08%) |
RBL2;HRAS;CDK2;...
|
| Riboflavin metabolism |
-1.45 |
3.19e-1 |
7/8 (87.5%) |
BLVRB;RFK;ACP1;...
|
| Lysosome |
-1.46 |
3.08e-1 |
115/128 (89.84%) |
IGF2R;CTSS;CD164;...
|
| Aldosterone-regulated sodium reabsorption |
-1.50 |
2.45e-1 |
34/37 (91.89%) |
NEDD4L;ATP1A3;SFN;...
|
| Glyoxylate and dicarboxylate metabolism |
-1.50 |
2.59e-1 |
23/30 (76.67%) |
MDH1;CS;PCCB;...
|
| Endometrial cancer |
-1.50 |
2.69e-1 |
56/58 (96.55%) |
HRAS;GADD45G;SOS2;...
|
| Biosynthesis of unsaturated fatty acids |
-1.50 |
2.92e-1 |
21/27 (77.78%) |
ACOX3;TECR;SCD;...
|
| Mitophagy |
-1.52 |
2.65e-1 |
56/68 (82.35%) |
MFN1;UBC;MFN2;...
|
| Ferroptosis |
-1.52 |
2.91e-1 |
36/41 (87.8%) |
FTH1;CYBB;MAP1LC3B;...
|
| Long-term potentiation |
-1.54 |
2.72e-1 |
61/67 (91.04%) |
ITPR2;PPP3R1;BRAF;...
|
| Nicotinate and nicotinamide metabolism |
-1.57 |
2.33e-1 |
25/35 (71.43%) |
SIRT7;NNMT;NNT;...
|
| Propanoate metabolism |
-1.62 |
1.90e-1 |
30/34 (88.24%) |
PCCB;SUCLA2;LDHA;...
|
| mTOR signaling pathway |
-1.64 |
1.77e-1 |
114/154 (74.03%) |
HRAS;IKBKB;RHOA;...
|
| Synaptic vesicle cycle |
-1.71 |
1.08e-1 |
63/78 (80.77%) |
CLTB;NAPA;SLC1A6;...
|
| Valine, leucine and isoleucine degradation |
-1.74 |
8.30e-2 |
42/48 (87.5%) |
HMGCL;ACAA1;PCCB;...
|
| Autophagy |
-1.78 |
8.01e-2 |
113/169 (66.86%) |
ATG7;PPP2CB;ATG13;...
|
| Collecting duct acid secretion |
-1.79 |
1.14e-1 |
22/27 (81.48%) |
ATP6V1G1;ATP6V0A2;ATP6V1D;...
|
| PPAR signaling pathway |
-1.82 |
1.72e-1 |
66/74 (89.19%) |
ME3;NR1H3;ACSL3;...
|
